Dharmesh Shah

Biography

BDR was founded by the indomitable, self –styled and self motivated Mr. Dharmesh Shah in 2003 who is the Chairman Managing Director of the group. Mr. Shah graduated as a Chemical Engineer from Mumbai University in 1987, and commenced his chequered career with manufacturing metallic stearates for the pharmaceutical, paint, tyre and HDPE LDPE granules Industry.Subsequently in the year 1998, Mr. Shah took over the marketing responsibilities of Khojchem Pvt. Ltd, which was then the leading manufacturer of multi vitamin base APIs like Niacin and Niacinamide, and Antitubercilosis like Isoniazide and marketing focused at both local and international pharmaceutical clientele.During this period he is also credited with identification and launching of more than 140 molecules for the first time ever in India and 2nd time in the world market after the Originator. Between 1997 and 2003, Hetero Group, thanks to marketing acumen of Mr. Shah became the leading producer and the marketer of HIV/AIDS molecules, particularly in Latin America, Middle East, Sub-Sahara and Africa. BDR was founded by the indomitable, self –styled and self motivated Mr. Dharmesh Shah in 2003 who is the Chairman Managing Director of the group. Mr. Shah graduated as a Chemical Engineer from Mumbai University in 1987, and commenced his chequered career with manufacturing metallic stearates for the pharmaceutical, paint, tyre and HDPE LDPE granules Industry.Subsequently in the year 1998, Mr. Shah took over the marketing responsibilities of Khojchem Pvt. Ltd, which was then the leading manufacturer of multi vitamin base APIs like Niacin and Niacinamide, and Antitubercilosis like Isoniazide and marketing focused at both local and international pharmaceutical clientele.During this period he is also credited with identification and launching of more than 140 molecules for the first time ever in India and 2nd time in the world market after the Originator. Between 1997 and 2003, Hetero Group, thanks to marketing acumen of Mr. Shah became the leading producer and the marketer of HIV/AIDS molecules, particularly in Latin America, Middle East, Sub-Sahara and Africa.

Research Interest

pharmaceutical industry.